In poorly perfused myocardium with resultant ischemic dysfunction, augmentation of contractility can, under certain conditions, be used to detect viable but ordinarily noncontracting muscle. Two methods of inotropic augmentation, pharmacologic inotropic stimulation and postextrasystolic potentiation (PESP), were studied in acutely ischemic canine myocardium with controlled coronary blood flow. A caliper length gauge to record segmental shortening and left ventricular pressure was used to construct pressure-length loops. Acute regional ischemia depressed segmental function: early segmental shortening decreased (-20 ± 0.02%[SE]) and frequent dyskinesia occurred. Restoring coronary blood flow corrected segmental shortening to control levels. During acute regional ischemia, PESP consistently augmented segmental function (+49 ± 0.03%) and abolished dyskinesia. Pharmacologic inotropic stimulation with isoproterenol or calcium administered into the coronary arteries did not produce a comparable improvement in segmental function (+9 ± 0.05%). Although early shortening markedly increased with pharmacologic stimulation, there was no consistent change in total shortening, and the area of the pressure-length loop decreased. Due to late dyskinesia, there was a decrease in injection shortening. Systemically administered pharmacologic agents accentuated early dyskinesia but caused no consistent change in total shortening. Unlike PESP, pharmacologic agents either worsened segmental function or caused responses that were minimum and inconsistent; such responses clearly cannot be used to identify viable ischemic myocardium.
• Present evidence indicates that coronary revascularization may correct segmental dysfunction in some patients with coronary artery disease (1, 2) . This correction of a functional deficit implies that flow is restored to areas of myocardial muscle that are viable although ischemic. Detection of such areas of viable but poorly perfused myocardium may be critically important to the optimization of the benefits of coronary bypass surgery.
Pharmacologic inotropic stimulation has been proposed as a method of detecting viable ischemic myocardium in man (3) . In dogs, systolic bulging of the left ventricle following occlusion of the left anterior descending coronary artery can be reduced by the administration of isoproterenol or calcium (4) . However, in ischemic muscle the response to Received May 13, 1974 . Accepted for publication Januarv 3, 1975. positive inotropic interventions may be attenuated (5) . Moreover, when coronary blood flow is limited, sustained inotropic interventions may augment oxygen requirements without enhancing the supply and thus produce a secondary ischemic depression of myocardial function (5) .
Postextrasystolic potentiation (PESP) of cardiac contractility was first demonstrated by Langendorff (6) and has subsequently been shown to be a fundamental characteristic of both normal and depressed mammalian myocardium (7) . Continuous paired stimulation of normal myocardium results in a substantial, sustained augmentation of myocardial contractility (7) and represents a maximum inotropic drive to cardiac muscle (8) . In the ischemic myocardium, continuous paired stimulation induces an initial augmentation of contractility that cannot be sustained; this initial response is followed by substantial depression (5) . The initial augmentation of contractility in the ischemic muscle, however, suggests that PESP following a single paired extrasystole might serve to identify viable but poorly perfused myocardium. Therefore, the present study was done to compare the effects of PESP and pharmacologic inotropic agents on acutely ischemic muscle.
Methods
Studies were performed on adult mongrel dogs (15-25 kg) anesthetized with sodium pentobarbital (25 mg/kg, iv). Endotracheal ventilation was maintained with a mixture of room air and oxygen. Following a left thoracotomy, the heart was supported in a pericardial cradle. The left anterior descending coronary artery was cannulated with a 14-or 16-gauge metal cannula distal to the first diagonal branch and perfused from a femoral artery. The perfusion pressure was controlled using a constant-flow pump (Sigmamotor). Ischemia could be electively induced by reducing the flow in this circuit.
A caliper length gauge (9) was placed in the distribution of the cannulated artery and oriented so that it measured the circumferential motion of the ventricular wall. The gauge was coupled to the myocardium with long pins attached to its feet and with epicardial sutures. The calibration of the gauge was linear, i.e., lateral motion of the legs of the gauge reflected a linear change in distance between the feet. The initial length of the gauge was set arbitrarily. A bipolar pacing electrode was placed in the right ventricular outflow tract. The left ventricular cavity was cannulated through a left atriotomy with a short steel cannula ( Fig. 1 ).
Coronary perfusion pressure and left ventricular pressure (P) were recorded using Statham P23Db strain gauges. Left ventricular dP/dt was obtained using a resistance-capacitance differentiation circuit exhibiting a constant phase shift of 90 ± 1° from 0 to 160 cps. Data were recorded on a light-writing recorder (Honeywell Visicorder) at 200 mm/sec and on a pen-writing recorder (Brush) at 25 mm/sec. Photographs of the course of segment length relative to left ventricular pressure were obtained from a storage oscilloscope.
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FIGURE 1
Schematic diagram of the experimental model. Controlled perfusion of the left anterior descending coronary artery was provided from the femoral artery. Perfusion pressure and left ventricular pressure were monitored. A caliper length gauge was oriented circumferentially in the distribution of the left anterior descending coronary artery. The gauge was attached using deep penetrating pins and epicardial sutures (insert).
Circulation Research. Vol. 36. April 1975 Representative data obtained from this preparation are shown in Figure 2 . During the control state, segmental shortening begins at point A, which is coincident with the initial rise of left ventricular pressure (end-diastole), and continues until ventricular pressure falls to its diastolic nadir at point E (end-systole); segmental lengthening occurs from end-systole to end-diastole of the next beat (E to A). Figure 2 (top) shows a pressure-segment length loop obtained in these experiments. Beginning at end-diastole (A), the loop is inscribed counterclockwise (B to E). Five parameters were determined: (1) total shortening (length change from the longest length to the shortest length [A to E]), (2) shortening during ventricular ejection (B to D), (3) area of the left ventricular pressure-segment length loop, (4) segment length at peak systolic pressure (C), and (5) time to peak shortening.
A SINGLE PAIRED ELECTRICAL STIMULATION (PESP)
Single extrasystoles were produced by electrical stimulation (2 msec, 1-4 ma) from the right ventricular pacing electrode. 1 The interval between the QRS complex and the stimulus could be varied. In the present experiment, maximum augmentation (100% increase) occurred before the peak of the T wave ( Fig. 3 ). Thus, a single paired electrical stimulation was placed in the cycle immediately after emergence from the refractory period. The effects of this paired electrical stimulation (PESP) were investigated during a control state and an ischemic state characterized by a reduction in coronary perfusion from control levels by an average of 64% (e.g., Fig. 4A -C). The duration of the ischemia usually was less than 5 minutes, but in some dogs it was extended to as long as 30 minutes.
PHARMACOLOGIC INOTROPIC STIMULATION
The effects of pharmacologic inotropic stimulation were investigated during a control state and an ischemic state like that used in the PESP study. Isoproterenol or calcium was infused systemically (iv) or locally (ic) into the cannulated segment. Doses were chosen so that the augmentation of left ventricular dP/dt induced by either drug given locally or systemically was approximately the same (isoproterenol 2 mg/min, iv, and 0.2 mg/min, ic; calcium 260 mg/min, iv, and 26 mg/min, ic). Figure 4 shows the typical effects of acute regional ischemia on segmental shortening; similar results were obtained in 43 experiments on 12 dogs. Reduction of coronary pressure caused a rapid depression of segmental myocardial function in 15 seconds ( Fig. 4A -C). The pattern of altered segmental shortening during ischemia was reproducible. Characteristically, early shortening was decreased, and frequently bulging of the segment occurred in early systole. The shortening of the segment that did occur was seen late in systole during the period when left ventricular pressure was falling toward diastolic levels. Reperfusion (D) restored segment length and function to control levels. Table 1 summarizes the data from the 12 dogs showing the effects of acute regional ischemia on segmental function. With a decrease in coronary pressure averaging 64%, total shortening fell 20 ± 0.02% (P < 0.05), shortening during ejection fell 58 ± 0.07% (P < 0.05), and the area of the pressurelength loop fell 50 ± 0.04% (P < 0.05). Left ventricular dP/dt declined only 4 ± 0.02% (P < 0.05).
Results
EFFECTS OF ACUTE REGIONAL ISCHEMIA
EFFECTS OF A SINGLE PAIRED ELECTRICAL STIMULATION (PESP)
The effects of a single paired electrical stimulation on segmental myocardial function are shown in Figure 5 . During the control period (A), the extrasystole caused a slight mechanical contraction followed by a compensatory pause. The subsequent beat was markedly potentiated with augmentation of segmental function (PESP). Starting from a longer end-diastolic length, total segmental shortening, shortening of the segment during ejection, and area of the pressure-segment length loop were increased. In addition, left ventricular pressure was increased. Figure 5B shows the effects of a single paired electrical stimulation on segmental function during acute severe ischemia. Following 30 minutes of total occlusion, diastolic segment length was increased, and the myocardial segment displayed a total loss of shortening during systole. Shortening beyond end-diastolic length occurred only late in systole when left ventricular pressure had fallen to diastolic levels. This late shortening was minimum and probably passive. However, PESP of the ischemic segment was still evident. During recovery (C), segmental function was restored to near control values. Similar results were obtained in 14 experiments in six dogs. As shown in Table 1 , potentiation of segment function was noted consistently, although left ventricular dP/dt increased 100 ± 0.11% (P < 0.05). Early or late systolic bulging ceased, and total shortening increased 49 ± 0.03% (P < 0.05), shortening during ejection rose 123 ± 0.08% (P < 0.05), and area of the pressurelength loop increased 144 ± 0.08% (P < 0.05).
EFFECTS OF PHARMACOLOGIC INOTROPIC STIMULATION
The effects of intracoronary administration of isoproterenol on the function of the ischemic myocardial segment (coronary perfusion pressure 45 mm Hg) are shown in Figure 6 Effect of the QRS-stimulus interval on postextrasystolic potentiation (PESP) during ischemia. The time (msec) of the stimulus from the onset of the QRS complex is shown on the horizontal line. The percent increase in shortening during ejection induced by PESP is shown on the vertical line. Maximum augmentation (100% increase) occurred early on the initial slope of the T wave, with a lesser amount of augmentation (less than a 50% increase) at and after the peak of the T wave. Effect of acute reversible ischemia on segmental myocardial and left ventricular function. The top three lines show the primary data of simultaneous left ventricular pressure (LVP), left ventricular (LV) dP/dt, and myocardial segment length at several levels of coronary pressure (CP), and the bottom two lines show segment length data like that described in Figure 2 . A: Control state. B and C: Progressive increments of acute ischemia. The two loops in C reflect the presence of pulsus alternans. D: Reperfusion and return to control state. marked increase in early segmental shortening. The length at peak systolic pressure was shorter, and the time to peak shortening was decreased 51 ± 0.05% (P < 0.05). Table 1 summarizes the data from 11 experi-ments with isoproterenol in six dogs. There was no consistent change in total shortening (9 ± 0.05%), although it was slightly increased by intracoronary administration of calcium (24 ± 0.07%, P < 0.05).
INOTROPIC STIMULATION IN ACUTE
Segmental function was always worsened by local Values are means ± SE. N = * P < 0.05. administration of inotropic stimulation. The area of the pressure-length loop decreased 148 ± 0.18% (P < 0.05), and due to late systolic bulging shortening during ejection decreased 180 ± 0.21% (P < 0.05). Often, net shortening during ejection was negative with a longer length at end-ejection relative to that at the beginning of ejection due to early relaxation. In parallel with the early augmentation of shortening, peak left ventricular dP/dt increased 44 ± 0.09% (P < 0.05). The effects of systemically administered isoproterenol on segmental function during ischemia (coronary perfusion pressure 45 mm Hg) are shown in Figure 6 (bottom). A summary from 18 experiments in seven dogs is given in Table 1 . Again, calcium produced similar changes. Left ventricular dP/dt increased 38 ± 0.04% (P < 0.05). Early bulging was accentuated, and segment length at peak systolic pressure was slightly longer. There was no consistent change in total shortening (0.0 ± 0.03%), although shortening late in systole was occasionally increased. On several occasions, these agents induced pulsus alternans or increased the alternans due to ischemia. The time to peak shortening decreased 10 ± 0.02% (P < 0.05). There was no significant change in the area of the pressure-length loop (18 ± 0.01%); however, ejection shortening increased 34 ± 0.13% (P < 0.05).
A comparison of the effects of systemically administered isoproterenol and a single paired extrasystole (PESP) during the same state of ischemia (coronary perfusion pressure 34 mm Hg) is shown in Figure 7 . In the experiment involving PESP, two ischemic beats showing depressed function and slight alternans preceded the extrasystole. In these beats, early systolic lengthening occurred followed by late shortening as left ventricular pressure was falling. The extrasystole produced minor mechanical activity and was followed by a compensatory pause. The subsequent beat was markedly potentiated, and the early systolic lengthening was abolished. Total shortening, ejection shortening, and the area of the pressure-segment length loop were increased, indicating sub- Vol. 36. April 1975 stantial augmentation of segmental and left ventricular function with an increase in left ventricular dP/dt. At comparable levels of ischemia, systemically administered isoproterenol increased left ventricular dP/dt but caused mechanical alternans of the segment with increased early systolic bulging. In the stronger beat of the alternans, the total shortening and the shortening during ejection were increased compared with those parameters during ischemia alone (i.e., the first two beats of Fig. 7,  left) . However, these changes were due to shortening from longer lengths as a result of the increased early systolic bulging with subsequent shortening in late systole. Even in the stronger beat, effective segmental motion was increased only slightly, whereas in the weaker beat it was less than that during ischemia. In contrast, PESP was characterized by marked normalization of all parameters of segmental function. Comparison of the effects of systemically administered pharmacologic inotropic agents (right) and PESP (left) during the same ischemic state. See legend to Figure 4 for explanation. LVP = left ventricular pressure, and CP = coronary pressure.
Discussion
The detection of ischemic but viable muscle has recently become clinically important, since restoration of flow to this muscle may improve segmental and ventricular function under both acute and chronic conditions. Chronic segmental dysfunction can be reversible particularly following successful revascularization of the ischemic heart (1, 2) . Observation of the response to inotropic stimulation has been proposed as a way of detecting dysfunction in ischemic yet viable myocardium (3). Systemically administered epinephrine induces improvement in regions of ventricular akinesia or hypokinesia in some patients with coronary artery disease (3). Experimentally, it has been shown that intracoronary administration of isoproterenol or calcium can decrease or abolish early systolic expansion in ischemic regions (4) . Furthermore, systemically administered isoproterenol can increase contractile force in an ischemic area (10) , although this increase cannot be sustained (5) and depression may follow due to increased oxygen requirements (11) in the absence of an augmented coronary blood flow.
The results of the present study indicate that, although pharmacologic inotropic stimulation with isoproterenol or calcium may reveal residual function in acutely ischemic muscle, the response is minimum and often inconsistent. On the other hand, the introduction of a properly timed extrasystole results in consistent and significant improvement of segmental shortening during the subsequent beat. Moreover, the single-beat augmentation, although it may increase energy needs for a single beat, does not produce prolonged secondary myocardial depression due to augmented oxygen needs.
Regional ischemia induces a characteristic, reversible pattern of early*systolic expansion followed by shortening in late systole when left ventricular pressure is falling to low levels (12) . Intracoronary administration of calcium or isoproterenol in the presence of ischemia supplants this abnormal pattern of shortening with an equally abnormal but different pattern, i.e., marked early systolic shortening followed by late systolic expansion. Segmental function appears to be worse during the pharmacologic stimulation than it is during ischemia alone. Thus, a segment showing hypokinetic but relatively normal shortening is converted to one showing late paradoxical motion (dyskinesia) (Fig.  2) . Intracoronary injections primarily affect the segment perfused by the artery (13) . Since both calcium and isoproterenol increase the speed of muscle contraction and shorten the duration of contraction, they change the time course of contraction in the ischemic segment in relation to that in the remaining normal muscle. Thus, the ischemic segment contracts maximally very early, and the late bulging is probably caused by the later contraction of the normal muscle in the remaining parts of the left ventricle, interacting with the more rapidly relaxing ischemic segment. Although viability of the ischemic area is thus clearly identified by the replacement of early akinesia with marked but abbreviated shortening, the practical opportunity to perfuse only an akinetic area of myocardium with an inotropic agent is quite limited.
Responses of the ischemic myocardium to the systemic administration of pharmacologic inotropic stimulation are inconsistent. Unlike local inotropic stimulation, this procedure never results in a change in the basic pattern of shortening during ischemia. However, systemic use of these agents frequently increases the degree of early systolic expansion with some augmentation of late shortening beginning about the time of peak pressure. Since this later shortening follows enhanced early expansion, the net shortening during systole is unchanged. Although enhancement of performance of the ischemic segment is sometimes seen following systemic inotropic stimulation, the absence of such a response clearly cannot be used to infer nonviability. Recent data indicate that the effect of inotropic agents may be attenuated in ischemic muscle (5) . Thus, the effect of systemically administered agents may reflect differential effects of the agents on normal and ischemic muscle. Enhanced contractility in the normal muscle may cause early systolic expansion of the ischemic muscle. In addition, these changes may also reflect a differential ability to enhance oxygen supply to meet the increased oxygen consumption induced by the inotropic agent (11) .
Other studies have suggested that pharmacologic inotropic stimulation in the presence of regional ischemia can have detrimental effects. Isoproterenol can extend the area of ischemia and injury, presumably because of increased myocardial oxygen consumption (14) .
In comparison to the pharmacologic agents, PESP is consistent in demonstrating residual function and thus viability. Left ventricular dP/dt increases (Table 1 ) and the segmental shortening pattern is normalized. In addition, PESP can be demonstrated for at least 30 minutes after total coronary artery occlusion (Fig. 5) at a time when the ischemic segment is doing no useful work.
The magnitude of PESP depends on the QRSstimulus interval preceding the augmented beat. The more premature the extrasystole, the greater the subsequent augmentation. In this study, maximum augmentation occurred when the premature stimulus was introduced before the peak of the T wave. Although this time dependence of PESP has been noted previously (15, 16) , it may account for the lack of effect of extrasystoles noted during ischemia in other studies (10) and of spontaneous extrasystoles for which this interval is variable and potentially long.
As demonstrated by the loops, in the present experiments the filling pressures were normal and the changes during ischemia were minor, since only a segment of the myocardium was made ischemic. The changes in motion of the loops were apparently not significantly dependent on volume, and a small increase in end-diastole volume did not restore the inappropriate motion of the ischemic area.
Preliminary data indicate that PESP can also improve ventricular performance and enhance segmental function in patients with coronary artery disease (17) . Furthermore, the initial observations in man have revealed that the extrasystole must be introduced later in the electrical cycle (after the T wave) to obtain depolarization and PESP (17) . Even though repetitive firing has occurred with stimuli introduced at nearly all parts of the electrical cycle in the dog (18) , the initiation of ventricular tachycardia or fibrillation was not encountered in 15 patients with coronary artery disease (17) . Thus, although the vulnerable period is close to the peak of the T wave and, in ischemic muscle, becomes wider with the threshold for ventricular tachycardia and fibrillation decreasing due to both ischemia (19) and the extrasystole (20) , this theoretical consideration does not appear to be a major limiting factor in clinical use of this technique. In summary, these experiments demonstrate that a single extrasystole producing PESP can help to identify viability in acutely ischemic muscle. Investigators now have the capacity to repeatedly determine inotropic contractile reserve, which may not be evident during ambient conditions, without augmenting oxygen needs, which may further worsen the degree of ischemia. Pharmacologic agents augment oxygen requirements and therefore can have deleterious effects in ischemic muscle. It is hoped that the preoperative use of PESP will assist in detecting ischemic but viable muscle in patients with coronary artery disease so that the benefits of coronary bypass surgery can be optimized.
